2023-12-29 21:04:47
Pharma » Developing the drugs of the future. This is the ambition of a start-up established in Bellinzona for a little over a year, and which is attracting international attention. This is Peptone, a translational biophysics company, a process which consists of producing concrete applications from knowledge resulting from fundamental research. Specializing in the study of molecules, the young company focuses on the discovery of new therapies to combat pathologies caused by intrinsically disordered proteins (IDPs).
“PIDs are proteins without a fixed structure, which play an important role in disease. They are involved in a large number of degenerative disorders, notably Alzheimer’s and Parkinson’s,” explains Kamil Tamiola, CEO and founder of the young biotechnology company born in 2018 in London. “These proteins are absolutely fascinating and we are working to unravel their mysteries,” he explains.
40
A million
1703884897
#Ticino #startup #intends #revolutionize #cancer #treatments #artificial #intelligence